Cost-Utility Analysis (CUA) of Belimumab (BEL) in the...

Cost-Utility Analysis (CUA) of Belimumab (BEL) in the Treatment of Adult Patients with Active, Autoantibody-Positive Systemic Lupus Erythematosus (SLE)

Walczak, J., Kopel, J., Sołtys, E., Dziurda, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2013.08.359
Date:
November, 2013
File:
PDF, 58 KB
english, 2013
Conversion to is in progress
Conversion to is failed